General Information
Revision date
2016-06-02
Product name
Pramipexole Dihydrochloride Tablets
Product Synonyms
Pramipexole Dihydrochloride Tablets, USP
Chemical name
(S)-2-amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole
CAS No.
191217-81-9
1.2.1 Relevant identified uses
Parkinson’s disease and Restless Legs Syndrome (RLS)
Manufacturer Name
ScieGen Pharmaceuticals, Inc
Icons in SDS
Company Information
company name
ScieGen Pharmaceuticals, Inc
Section 2
SECTION 2: Hazards identification
Appearance White tablets
Hazard statements
Non-hazardous in accordance with international standards for workplace safety.
Additional information
Not a skin irritant, Not acutely toxic (based on components) . Ingestion may cause lowering of blood pressure. Short Term: Long Term: Animal studies indicate that this material may cause adverse effects on the eyes. Known Clinical Adverse effects most commonly reported in clinical use include hallucinations, Effects: drowsiness, sleepiness, dizziness, sedation, and gastrointestinal disturbance. EU Indication of Not classified danger
